Biological Basis of Cancer Therapy Part A: Pharmacology, Chemotherapy and Molecular Biology (FRCR 1) Recordings

Monday 7 to Friday 11 November 2022 - virtual via Live Zoom

The Cancer Studies Research Group based at The Christie School of Oncology and Cancer Research UK Manchester Institute play a major role in allowing specialist registrars in clinical and medical oncology to fulfil the academic side of their training.

This programme is run as a 5-day lecture series and includes examination practice sessions. Monday to Wednesday will focus on molecular biology and immunotherapy, and Thursday and Friday will cover pharmacology and chemotherapy.

Low-to-Middle-Income Country (LMIC) course fees are offered at a 50% reduction. Countries eligible for LMIC reduced rate can be found on The World Bank website.  Countries listed under the headings "Low-Income Economies" and Lower-Middle-Income Economies" will be considered.  

If you are currently living in an LMIC, please email julie.edwards@cruk.manchester.ac.uk attaching proof of employment from your current hospital/institute before booking and completing registration on Eventbrite.

The teaching is a Royal College Accredited training course designed for clinical and medical oncology specialist registrars (clinical pharmacology, chemotherapy and molecular biology).

The course covers FRCR part 1 examinations as part of the RCR syllabus.

  • Pharmacology and drug toxicity
  • Pharmacokinetics
  • Angiogenesis
  • Immunotherapy and vaccines
  • Cancer genetics
  • Apoptosis
  • Clinical pharmacology
  • High dose chemotherapy
  • Exam practice sessions
  • Chemotherapy principles and drug resistance

Sign up to our education events mailing list to be kept up to date with this and future events

Last updated: May 2023

© 2023 The Christie NHS Foundation Trust